Navigation Links
MRSA and C. difficile Infections Reduced by 50% in Hospital Study
Date:12/1/2008

ROME, N.Y., Dec. 1 /PRNewswire/ -- To help prevent the spread of germs and protect its patients from infections, Rome Memorial Hospital is using two new products that kill germs on hands and surfaces between cleanings.

According to Infection Prevention Director LeAnna Grace, the hospital conducted a 12-month research study of Germ Pro's new surface disinfectant and hand sanitizing lotion to evaluate how well they work and was excited by the results.

"At Rome Memorial Hospital, we have an excellent record of protecting our patients from getting an infection during their hospital stay because we follow the infection control guidelines developed by the Centers for Disease Control and Prevention (CDC)," Grace said. "But, even one healthcare associated infection is too many. That's why we're always looking for better ways to kill germs."

While testing the new technology of Germ Pro's Persistent Action Plan, Rome Memorial Hospital reduced Healthcare Associated Infections (HAIs) by 27.4%, the study concluded. "Use of Germ Pro in combination with our ongoing infection prevention strategies, reduced two of the more dangerous infections -- methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C. difficile) by more than 50%," Grace noted.

"We haven't had a central line infection in a year. We haven't had a post-operative pneumonia in more than a year. In the final phase of the study, we implemented Germ Pro house-wide in May and haven't had a single HAI- MRSA case since," Grace said.

The CDC's hand hygiene guidelines require caregivers to wash their hands or use alcohol-based sanitizers before and after touching any patient. Hospitals also use effective disinfectants to kill germs on surfaces. These products kill germs at the time of use, but don't have any persistent killing power between cleanings. With traditional products, germs can easily be reintroduced to clean surfaces by visitors, patients and staff.

"It's just like at home. You finish cleaning the kitchen and no sooner turn around and there are fingerprints on the refrigerator," Grace said. "The beauty of the Germ Pro products is they keep working between cleanings so it's less likely for germs to multiply and spread."

According to Germ Pro President Wayne Albright, Germ Pro's Hand Sanitizing Lotion and Surface Disinfectant were proven by laboratory testing as required by the Food and Drug Administration and the Environmental Protection Agency.

"We focused our efforts on developing a 'Persistent Action Plan' to give healthcare providers an additional tool to protect patients from the two million healthcare associated infections that occur annually in the United States," he said. "If you persistently kill the germs on your hands and the surfaces that your hands touch, you will not easily be able to pick up or transmit infections."

"MRSA and C. difficile have developed a resistance to some antibiotics, and multi-drug resistant germs are more common and a serious concern at all hospitals," Albright said. "While HAIs drive up the cost of healthcare by an estimated $30 billion, the cost to patients and their families is incalculable."

"RMH was the first hospital to add this new technology to their infection prevention program. Its management was very proactive in their desire to improve patient safety by preventing infections," Albright said.

He praised Grace and Building Services Assistant Director Fred White for their diligence in implementing Germ Pro and commended the doctors, nurses, and other hospital workers for their support in this effort to improve patient safety.

"Results from this study were outstanding and have convinced other major hospitals to follow RMH's lead. RMH should be commended for their role in this very significant improvement in hospital care," he said. "Overall infections reduction of 27.4% is excellent, and more than 50% improvement in MRSA and C. difficile is outstanding. It greatly improves patient safety and significantly reduces healthcare cost."

How Germ Pro Works

Germ Pro's Hand Sanitizing Lotion is used in addition to normal hand hygiene guidelines. Healthcare workers apply the alcohol-free lotion at the beginning of the day and again every three to four hours. The lotion kills germs persistently for four to six hours and does not easily wash off. As an added benefit, it protects healthcare workers' hands from alcohol-based sanitizers that can cause drying and cracking.

Germ Pro's Surface Disinfectant is applied monthly after normal cleaning and disinfecting and reapplied in patient rooms after each patient is discharged. Based upon laboratory tests, it kills germs persistently for up to 28 days. The disinfectant is only applied to common "touch points" such as doors, handles, countertops, telephone, remotes, bedrails, bathroom surfaces, wheelchairs, gurneys, elevator buttons and computer keyboards.

For more information about Germ Pro, visit www.GermProProducts.com or send an e-mail to GermPro@yahoo.com.


'/>"/>
SOURCE Germ Pro Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New Report Shows High C-difficile Infection Rates in U.S. Hospitals
2. Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
3. Advances in C. difficile research
4. APIC Launches First National C. Difficile Prevalence Study
5. APIC launches first national C. difficile prevalence study
6. National Experts Team Up to Help Hospitals Prevent and Control C. difficile Outbreaks
7. Cranberries May Help Prevent Urinary Tract Infections
8. FDA Issues Complete Response Letter for Ceftobiprole for Treatment of Complicated Skin Infections
9. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
10. Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections
11. Zero MRSA or Patient Infections Reported After Two Years as D.I.S.C. Sports and Spine Center Sets New Standard for Specialty Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name Medical ... York, NY, on December 3rd, to benefit Holy Name Medical Center's programs and ... which raised over $1 million - the largest event in the Center's history, ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical ... 2017. The name change aligns the entire company with its existing Quality ... quality. , “We are very proud of the achievements associated with the West ...
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc , a New ... Conventional Data Capture Methods for Input to Electronic Health Records: A Comparative Usability ... the comparative usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental ... dentists and patients about the safety issues related to dental restorations. According to the ... is projected to reach $6.4 billion in 2018 with more than 30 million Americans ...
(Date:12/8/2016)... ... December 08, 2016 , ... Launching ... innovative Unified Instance Manager architecture, meeting the needs of multichannel growth and ... the unattended auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... 9, 2016 Research and Markets has ... report to their offering. ... The report forecasts the global optical transceiver market ... The report covers the present scenario and the ... calculate the market size, the report considers the revenue generated from ...
(Date:12/9/2016)... Japan , Dec. 9, 2016 Mitsubishi ... ; President & Representative Director, CEO: Dr. Masayuki ... amyotrophic lateral sclerosis (ALS) given edaravone intravenously in 10-14 ... loss as measured by the ALS Functional Rating Scale-Revised ... International Symposium on ALS/MND in Dublin, ...
(Date:12/9/2016)... 2016 Research and Markets has announced the ... to their offering. ... The global travel vaccines market to grow at a CAGR ... the present scenario and the growth prospects of the global travel ... considers the revenue generated from the sales of various vaccines administered ...
Breaking Medicine Technology: